E-nose Assess Immunotherapy Prognosis
January 21, 2020 | Terry Sharrer

Analysis of exhaled breath
Oncologists at the Netherlands Cancer Institute “hypothesized that molecular profiling of exhaled air may capture the inflammatory milieu related to the individual responsiveness to anti-programmed death ligand 1 (PD-1) therapy. This study aimed to determine the accuracy of exhaled breath analysis at baseline for assessing nonresponders versus responders to anti-PD-1 therapy in NSCLC patients.” The electronic nose had greater accuracy than the current method of immunohistochemistry. MORE
Image Credit: Pexels


